Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HMGCR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
HMGCR is a gene implicated in neurodegeneration research. Key relationships include: associated with, interacts with, inhibits. Associated with AD, ALS, AMI. Connected to 244 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | HMGCR |
| Full Name | 3-Hydroxy-3-Methylglutaryl-CoA Reductase |
| Chromosome | 5 |
| Function | HMGCR plays a critical role in cholesterol metabolism, which is intimately connected to Alzheimer's disease pathogenesis through multiple mechanisms: |
| Pathways | Amyloid, Autophagy, Cholesterol, Cholesterol Metabolism, Lipid Metabolism |
| UniProt ID | [P04035](https://www.uniprot.org/uniprotkb/P04035/entry) |
| Ensembl ID | ENSG00000013113 |
| GeneCards | HMGCR |
| Human Protein Atlas | HMGCR |
| Associated Diseases | AD, Als, Alzheimer, Alzheimer disease, Alzheimer's disease |
| Known Drugs/Compounds | 25-Hydroxycholesterol, SIMVASTATIN, statins |
| Interactions | A2M, ABCA1, ACSL4, AGING, Akt, AKT |
| KG Connections | 836 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
HMGCR["HMGCR
HMG-CoA Reductase
Rate-limiting enzyme"]
Cholesterol["Cholesterol
Biosynthesis
Pathway"]
Statins["Statin Therapy
HMGCR Inhibition"]
APP["APP
Amyloid Precursor
Protein"]
PSEN1["PSEN1
Presenilin-1
gamma-secretase component"]
MAPT["MAPT
Tau Protein
Microtubule binding"]
Inflammation["Neuroinflammation
IL1B-mediated
responses"]
IL1B["IL1B
Interleukin-1beta
Pro-inflammatory"]
Apoptosis["Apoptosis
Pathway
Cell death"]
PARP1["PARP1
DNA repair
enzyme"]
DAPK1["DAPK1
Death-associated
protein kinase"]
Alzheimer["Alzheimer's
Disease"]
ALS["ALS
Motor neuron
degeneration"]
Dementia["Dementia
Cognitive decline"]
Depression["Depression
Mood disorder"]
HMGCR -->|"regulates"| Cholesterol
HMGCR -->|"interacts_with"| APP
HMGCR -->|"interacts_with"| PSEN1
HMGCR -->|"interacts_with"| MAPT
HMGCR -->|"inhibits"| Inflammation
HMGCR -->|"interacts_with"| IL1B
HMGCR -->|"modulates"| Apoptosis
HMGCR -->|"interacts_with"| PARP1
HMGCR -->|"interacts_with"| DAPK1
Statins -->|"inhibits"| HMGCR
APP -->|"contributes_to"| Alzheimer
PSEN1 -->|"contributes_to"| Alzheimer
MAPT -->|"contributes_to"| Alzheimer
HMGCR -->|"associated_with"| Alzheimer
HMGCR -->|"associated_with"| ALS
HMGCR -->|"therapeutic_target"| Dementia
HMGCR -->|"associated_with"| Depression
Apoptosis -->|"leads_to"| ALS
Inflammation -->|"contributes_to"| Alzheimer
style HMGCR fill:#006494
style Statins fill:#1b5e20
style Cholesterol fill:#4a1a6b
style Inflammation fill:#ef5350
style Apoptosis fill:#ef5350
style Alzheimer fill:#5d4400
style ALS fill:#5d4400
style Dementia fill:#5d4400
style Depression fill:#5d4400
style APP fill:#4a1a6b
style PSEN1 fill:#4a1a6b
style MAPT fill:#4a1a6b| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:HMGCR | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| cholesterol synthesis | upstream_of | process | 0.90 |
| lipid metabolism | participates_in | pathway | 0.80 |
| neurons | inhibits | cell_type | 0.80 |
| multiple sclerosis | implicated_in | disease | 0.80 |
| cerebral ischemic stroke | implicated_in | disease | 0.80 |
| excitotoxicity | inhibits | biological_process | 0.80 |
| apolipoprotein E | regulates | protein | 0.80 |
| pro-inflammatory/anti-inflammatory cytokines | balances | biological_process | 0.80 |
| matrix metalloproteinases | modulates | protein | 0.80 |
| reactive oxygen and nitrogen species | inhibits | biological_process | 0.80 |
| Amyloid-β | regulates | protein | 0.80 |
| cerebral blood perfusion | increases | biological_process | 0.80 |
| endothelial nitric oxide synthase | stimulates | protein | 0.80 |
| unfolded protein response | participates_in | pathway | 0.80 |
| oxidative stress response | participates_in | pathway | 0.70 |
| membrane lipid composition | modulates | mechanism | 0.70 |
| neurons | activates | cell_type | 0.70 |
| neural stem cells | regulates | cell_type | 0.70 |
| AKT | therapeutic_target | gene | 0.70 |
| Cholesterol | activates | pathway | 0.70 |
| Als | activates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ferroptosis | activates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Pyroptosis | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| SIMVASTATIN | inhibits | drug | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Cardiovascular | inhibits | disease | 0.65 |
| Cirrhosis | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:HMGCR | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| TDP-43 | binds | protein | 1.00 |
| h-a87702b6 | targets_gene | hypothesis | 0.90 |
| statins | inhibits | compound | 0.90 |
| TNF | upregulates | protein | 0.90 |
| 25-Hydroxycholesterol | modulates | compound | 0.85 |
| BECN1-HSPA5 complex | promotes | protein | 0.83 |
| statins | activates | compound | 0.80 |
| IL6 | interacts_with | gene | 0.70 |
| TNF | interacts_with | gene | 0.70 |
| IL1B | interacts_with | gene | 0.70 |
| PI3K | therapeutic_target | gene | 0.70 |
| CHOLESTEROL | destabilizes | phenotype | 0.65 |
| NF-KB SIGNALING | activates | pathway | 0.65 |
| BRCA2 | modifies | gene | 0.65 |
| NF-KB SIGNALING | regulates | pathway | 0.65 |
| LIPID PEROXIDATION | treats | phenotype | 0.65 |
| APOE4 | activates | gene | 0.65 |
| OPRM1 | associated_with | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| BECN1 | activates | gene | 0.60 |
| FASN | therapeutic_target | gene | 0.60 |
| FASN | expressed_in | entity | 0.60 |
| NEURODEGENERATIVE DISORDERS | activates | gene | 0.60 |
| SREBP-2 | regulates | protein | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| AMYLOID | regulates | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| HSPG2 | interacts_with | gene | 0.60 |
| DYNEIN | interacts_with | gene | 0.60 |
| SLC30A8 | associated_with | gene | 0.60 |
| SLC6A3 | associated_with | gene | 0.60 |
| SCD1 | activates | gene | 0.60 |
| NRP1 | activates | gene | 0.60 |
| APP | inhibits | gene | 0.60 |
| CXCL8 | therapeutic_target | gene | 0.60 |
| MMP3 | therapeutic_target | gene | 0.60 |
| ICAM1 | therapeutic_target | gene | 0.60 |
| INSC | activates | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| CCL20 | therapeutic_target | gene | 0.60 |
| PPAR | inhibits | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| ABCA1 | causes | gene | 0.60 |
| APOE | causes | gene | 0.60 |
| CYP46A1 | causes | gene | 0.60 |
| BDNF | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-08 | 0 hypotheses
neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.803
neurodegeneration | 2026-04-03 | 18 hypotheses Top: 0.847
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
closed · Rounds: 4 · Score: 0.90 · 2026-04-03